Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result
The 2025 TESTS trial is more informative than earlier small sepsis reports: 1,106 adults were randomized across 22 centers, and thymosin alpha-1…
Read source review →
Research Topic
Antimicrobial & Immune
Topic knowledge
Source-reviewed reading for antimicrobial & immune
Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 73–76 of 76 reviewed articles · Page 13 of 13
LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material
“LL-37” can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one…
Read source review →LL-37 at the Ocular Surface: Expression and In-Vitro Antimicrobial Data
A frequently cited LL-37 paper examined expression in human ocular-surface cells and antimicrobial activity in laboratory assays. It did not administer LL-37…
Read source review →Peptide Receiving and Storage: What to Check When a Shipment Arrives
Check peptide labels, packaging, batch documents and transport records, then confirm product-specific storage instructions before starting work.
Read source review →Need a peptide for antimicrobial & immune research?
If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.